Understanding and targeting the disease‐related RNA binding protein human antigen R (HuR)
Altered gene expression is a characteristic feature of many disease states such as
tumorigenesis, and in most cancers, it facilitates cancer cell survival and adaptation …
tumorigenesis, and in most cancers, it facilitates cancer cell survival and adaptation …
RNA-binding proteins and their role in kidney disease
L Seufert, T Benzing, M Ignarski… - Nature Reviews …, 2022 - nature.com
RNA-binding proteins (RBPs) are of fundamental importance for post-transcriptional gene
regulation and protein synthesis. They are required for pre-mRNA processing and for RNA …
regulation and protein synthesis. They are required for pre-mRNA processing and for RNA …
Autotaxin in pathophysiology and pulmonary fibrosis
I Ninou, C Magkrioti, V Aidinis - Frontiers in medicine, 2018 - frontiersin.org
Lysophospholipid signaling is emerging as a druggable regulator of pathophysiological
responses, and especially fibrosis, exemplified by the relative ongoing clinical trials in …
responses, and especially fibrosis, exemplified by the relative ongoing clinical trials in …
The expression regulation and biological function of autotaxin
X Zhang, M Li, N Yin, J Zhang - Cells, 2021 - mdpi.com
Autotaxin (ATX) is a secreted glycoprotein and functions as a key enzyme to produce
extracellular lysophosphatidic acid (LPA). LPA interacts with at least six G protein-coupled …
extracellular lysophosphatidic acid (LPA). LPA interacts with at least six G protein-coupled …
Targeting the RNA-binding protein HuR in cancer
The RNA-binding protein human antigen R (HuR) is a well-established regulator of gene
expression at the posttranscriptional level. Its dysregulation has been implicated in various …
expression at the posttranscriptional level. Its dysregulation has been implicated in various …
[HTML][HTML] Autotaxin–Lysophosphatidate axis: promoter of cancer development and possible therapeutic implications
C Laface, AD Ricci, S Vallarelli, C Ostuni… - International Journal of …, 2024 - mdpi.com
Autotaxin (ATX) is a member of the ectonucleotide pyrophosphate/phosphodiesterase
(ENPP) family; it is encoded by the ENPP2 gene. ATX is a secreted glycoprotein and …
(ENPP) family; it is encoded by the ENPP2 gene. ATX is a secreted glycoprotein and …
Autotaxin in breast cancer: role, epigenetic regulation and clinical implications
A Drosouni, M Panagopoulou, V Aidinis, E Chatzaki - Cancers, 2022 - mdpi.com
Simple Summary Autotaxin (ATX) has been linked with the pathogenesis of several cancers
and especially with breast cancer (BC). BC is one of the most common cancers among …
and especially with breast cancer (BC). BC is one of the most common cancers among …
The interplay between the RNA decay and translation machinery in eukaryotes
AM Heck, J Wilusz - Cold Spring Harbor Perspectives in …, 2018 - cshperspectives.cshlp.org
RNA decay plays a major role in regulating gene expression and is tightly networked with
other aspects of gene expression to effectively coordinate post-transcriptional regulation …
other aspects of gene expression to effectively coordinate post-transcriptional regulation …
HNRNPD interacts with ZHX2 regulating the vasculogenic mimicry formation of glioma cells via linc00707/miR-651-3p/SP2 axis
S Yu, X Ruan, X Liu, F Zhang, D Wang, Y Liu… - Cell Death & …, 2021 - nature.com
Studies have found that RNA-binding proteins (RBPs) are dysfunctional and play a
significant regulatory role in the development of glioma. Based on The Cancer Genome …
significant regulatory role in the development of glioma. Based on The Cancer Genome …
Coming of age for autotaxin and lysophosphatidate signaling: Clinical applications for preventing, detecting and targeting tumor-promoting inflammation
MGK Benesch, ITK MacIntyre, TPW McMullen… - Cancers, 2018 - mdpi.com
A quarter-century after the discovery of autotaxin in cell culture, the autotaxin-
lysophosphatidate (LPA)-lipid phosphate phosphatase axis is now a promising clinical …
lysophosphatidate (LPA)-lipid phosphate phosphatase axis is now a promising clinical …